No NHS Coverage for Janssen’s Spravato: NICE Denies Re-Appraisal of Esketamine for TRD

Finance

Reading Time: < 1 minute

Earlier this month, the National Institute for Health and Care Excellence (NICE), which stipulates which medical interventions are covered by England and Wales’ National Health Service (NHS), issued a statement that effectively brings Janssen’s ambitions to have its esketamine nasal spray (Spravato) product for treatment-resistant depression (TRD) reimbursed by the NHS in the UK’s most populous…
Source

Source link

Name*
First Last
Email*
Consent*
Yes, I would like to receive future communications from Investly Today.
Email
This field is for validation purposes and should be left unchanged.

Subscribe to receive the latest business and industry news in your inbox.

Name*
First Last
Email*
Consent*
Yes, I would like to receive future communications from Investly Today.
Email
This field is for validation purposes and should be left unchanged.

latest from the industry

PSYCHEDELICS news

Superior Anemometers: High accuracy and robust construction

Reading Time: 2 minutes Superior Anemometers is dedicated to designing and manufacturing high-quality wind measurement devices, offering products that

September 19, 2024

Parign Hak – Grandma's Home

Reading Time: < 1 minute Parign Hak – Grandma’s Home Find someone to connect with locally. Please reach out to

September 19, 2024

Finding Your Soul’s Purpose: Harnessing Psychedelic Insights for Professional Growth

Reading Time: 2 minutes Psychedelic experiences can be a key drivers toward finding your soul’s purpose. But how can

September 19, 2024

No NHS Coverage for Janssen’s Spravato: NICE Denies Re-Appraisal of Esketamine for TRD

Finance

Superior Anemometers: High accuracy and robust construction

Parign Hak – Grandma's Home

Finding Your Soul’s Purpose: Harnessing Psychedelic Insights for Professional Growth

COPYRIGHT 2022 @ investly.today ALL RIGHTS RESERVED

Whitepaper